The Atherosclerosis Research Center

 

History

The Atherosclerosis Research Center was launched in 2012 and started its activities officially in 2013.

Vision

Optimum use of the capacities of Baqiyatallah University of Medical Sciences and other related organizations in the field of control, prevention, and treatment of cardiovascular diseases, as well as the design and implementation of applied and knowledge-production research, in order to improve the health of society.

Mission

Improving the scientific and research level of the faculty members of the Atherosclerosis Research Center of Baqiyatallah University of Medical Sciences, improving the qualitative and quantitative level of innovative applied projects in the field of cardiology in order to improve the quality of treatment and prevention, as well as increasing the level of international scientific cooperation.

Road Map

• Prevention and promotion of health in the field of cardiovascular

• Identification of new biomarkers
• Genetic and molecular investigation of cardiovascular risk factors
• Prevention, diagnosis, and treatment of coronary artery occlusive diseases: premature atherosclerosis as the main cause of death in today’s society
• Reviews of nutritional and medicinal methods
• Cardiovascular risk factors (mental health and psychological factors related to cardiovascular health, etc.)
• Prevention through interaction with exercise physiology and behavioral science

 

• Bioinformatics in the field of cardiovascular diseases

• Research in the field of producing software and hardware related to diagnostic and treatment investigations of cardiovascular diseases
• Research in the field of producing software for calculating heart valve flows (failures, strictures) in prosthetic, native valves.
• Research in the field of production and development of electrocardiographs, electroshock machines, etc.
• Research in the field of the Internet of Things and the specialized field of cardiology
  • New arenas
• Development of cardiovascular research with a personal medicine approach
• A: Laboratory and clinical studies to control the efficacy of drugs.

 

• B: Controlled release of drugs to the heart in certain patients (stent implantation, heart clots, endocarditis, and heart infections).

 

• C: genetic and molecular investigation in certain patients.

 

• Tissue engineering of stem cells (A: Evaluation and application of stem cells: tissue engineering in acute coronary syndrome.
• B: Evaluation and application of stem cells—tissue engineering in heart failure.

• Research in the field of geriatrics.
• Synthetic biology (valve-stent).